| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 20 |
| 1 | CLOPIDOGREL | 17 |
| 2 | METOPROLOL TARTRATE | 16 |
| 3 | METOPROLOL | 15 |
| 4 | METOPROLOL TARTRATE INJECTION | 14 |
| 5 | CLOPIDOGREL BISULFATE | 13 |
| 6 | ASPIRIN | 12 |
| 7 | ASPIRIN 325 MG | 12 |
| 8 | ASPIRIN 81 MG | 12 |
| 9 | DABIGATRAN ETEXILATE MESYLATE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CASTOR OIL | 1 | 0.0052 |
| 1 | BIVALIRUDIN | 3 | 0.0030 |
| 2 | FOSCARNET SODIUM | 7 | 0.0017 |
| 3 | ANTI-INHIBITOR COAGULANT COMPLEX | 1 | 0.0009 |
| 4 | ETHIODIZED OIL | 1 | 0.0008 |
| 5 | LIDOCAINE AND PRILOCAINE | 1 | 0.0007 |
| 6 | ARGATROBAN | 1 | 0.0007 |
| 7 | SODIUM POLYSTYRENE SULFONATE | 1 | 0.0006 |
| 8 | SIROLIMUS | 8 | 0.0006 |
| 9 | DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 21 |
| 1 | Kinase Inhibitor [EPC] | 20 |
| 2 | Corticosteroid [EPC] | 15 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 15 |
| 4 | P2Y12 Platelet Inhibitor [EPC] | 15 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 13 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 12 |
| 7 | Alkylating Drug [EPC] | 11 |
| 8 | mTOR Inhibitor Immunosuppressant [EPC] | 10 |
| 9 | Azole Antifungal [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anti-coagulant [EPC] | 4 | 0.0011 |
| 1 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 2 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 3 | Bismuth [EPC] | 1 | 0.0002 |
| 4 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 5 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |
| 6 | P2Y12 Platelet Inhibitor [EPC] | 15 | 0.0001 |
| 7 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 4 | 0.0001 |
| 8 | Prostacyclin Receptor Agonist [EPC] | 3 | 0.0001 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |